Articles database
 
 
Web AnyArticles.com
Browse by Category:
  Health and Fitness >
  Subcategories
Acne Acne (416)
Aerobics Cardio Aerobics Cardio (70)
Alternative Alternative (1302)
Beauty Beauty (1143)
Build Muscle Build Muscle (398)
Depression Depression (386)
Diabetes Diabetes (189)
Exercise Exercise (573)
Fitness Equipment Fitness Equipment (391)
Hair Loss Hair Loss (308)
Medicine Medicine (650)
Meditation Meditation (152)
Men Issues Men Issues (320)
Nutrition Nutrition (1101)
Supplements Supplements (647)
Weight Loss Weight Loss (2225)
Women Issues Women Issues (487)
Yoga Yoga (212)


  Categories :
 
  Arts and Entertainment
  Automotive
  Business
  Communications
  Computers and Technology
  Finance
  Food and Drink
  Health and Fitness
  Home and Family
  Home Based Business
  Internet and Businesses Online
  Kids and Teens
  Legal
  News and Society
  Recreation and Sports
  Reference and Education
  Self Improvement
  Shopping and Product Reviews
  Travel and Leisure
  Womens Interests
  Writing and Speaking
  Random Category
  Pregnancy
  Elder care
  Funny stuff
Depression article : FDA Nears Completion of Review of Vagus Nerve Stimulation For Chronic Depression
 

Health and Fitness > Depression > FDA Nears Completion of Review of Vagus Nerve Stimulation For Chronic Depression

0 Reviews [ add review ], Article rating : 0.00, 0 votes. Author : Charles Donovan

On June 2 at 8:00 pm ET, Reuters news service issued a press release announcing that the FDA have nearly completed final review of the conditions outlined in the February "deemed approvable" letter for VNS Therapy as a treatment for chronic depression. Cyberonics Inc. said that the FDA had nearly completed final review of conditions outlined in the February approval of its implanted device for treatment of chronic depression.

The FDA approved the VNS Therapy System pending final labeling, protocols for a post-marketing dosing study and patient registry, as well as resolution of manufacturing issues and any outstanding clinical trial issues.

The company said a follow-up inspection of its Houston headquarters will begin on Monday. It also said four manuscripts from clinical trials of the device were accepted for publication in "respected psychiatric peer-reviewed journals."

In a statement, Chief Executive Skip Cummins said the company expects to launch sales of

the device for "treatment-resistant depression" once minor labeling changes are made and the follow-up inspection has been satisfactorily completed.

Cyberonics also said it has entered a formal quiet period with regard to all public communications pending a final FDA decision or other material information requiring disclosure.

In a statement, Chief Executive Skip Cummins said the company expects to launch sales of the device for "treatment-resistant depression" once minor labeling changes are made and the follow-up inspection has been satisfactorily completed.

Charles Donovan was a patient in the FDA investigational trial for vagus nerve stimulation and depression. After 25 years of chronic depression, vagus nerve stimulation completely cured his chronic depression. The author is so grateful and humbled by this remarkable device. He chronicles is journey in his book Out of The Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression

Learn more at his website: http://www.VagusNerveStimulator.com



0 Reviews [ add review ], Article rating : 0.00, 0 votes. Author : Charles Donovan
Rate this story : and read/post review(s)


Article reviews



Post your review
[ Note : no HTML/URLs - will removed automatically ]
Your name
Your comments


More articles from Health and Fitness > Depression

Add article | Manage Articles | Top Rated articles | Most Reviewed articles | Contact us | Links